前列腺癌的血清疗法革命:基础知识、临床应用、未决问题和未来展望

IF 10.5 1区 医学 Q1 ONCOLOGY Cancer treatment reviews Pub Date : 2024-03-01 Epub Date: 2024-02-11 DOI:10.1016/j.ctrv.2024.102698
Matteo Bauckneht , Chiara Ciccarese , Riccardo Laudicella , Claudia Mosillo , Francesca D'Amico , Annunziato Anghelone , Alessandro Strusi , Viria Beccia , Sergio Bracarda , Giuseppe Fornarini , Giampaolo Tortora , Roberto Iacovelli
{"title":"前列腺癌的血清疗法革命:基础知识、临床应用、未决问题和未来展望","authors":"Matteo Bauckneht ,&nbsp;Chiara Ciccarese ,&nbsp;Riccardo Laudicella ,&nbsp;Claudia Mosillo ,&nbsp;Francesca D'Amico ,&nbsp;Annunziato Anghelone ,&nbsp;Alessandro Strusi ,&nbsp;Viria Beccia ,&nbsp;Sergio Bracarda ,&nbsp;Giuseppe Fornarini ,&nbsp;Giampaolo Tortora ,&nbsp;Roberto Iacovelli","doi":"10.1016/j.ctrv.2024.102698","DOIUrl":null,"url":null,"abstract":"<div><p>In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.</p></div>","PeriodicalId":9537,"journal":{"name":"Cancer treatment reviews","volume":"124 ","pages":"Article 102698"},"PeriodicalIF":10.5000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0305737224000161/pdfft?md5=3dfb0b74c0926897345eea7f47243cf5&pid=1-s2.0-S0305737224000161-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives\",\"authors\":\"Matteo Bauckneht ,&nbsp;Chiara Ciccarese ,&nbsp;Riccardo Laudicella ,&nbsp;Claudia Mosillo ,&nbsp;Francesca D'Amico ,&nbsp;Annunziato Anghelone ,&nbsp;Alessandro Strusi ,&nbsp;Viria Beccia ,&nbsp;Sergio Bracarda ,&nbsp;Giuseppe Fornarini ,&nbsp;Giampaolo Tortora ,&nbsp;Roberto Iacovelli\",\"doi\":\"10.1016/j.ctrv.2024.102698\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.</p></div>\",\"PeriodicalId\":9537,\"journal\":{\"name\":\"Cancer treatment reviews\",\"volume\":\"124 \",\"pages\":\"Article 102698\"},\"PeriodicalIF\":10.5000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0305737224000161/pdfft?md5=3dfb0b74c0926897345eea7f47243cf5&pid=1-s2.0-S0305737224000161-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer treatment reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0305737224000161\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0305737224000161","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在过去几年中,前列腺癌治疗技术为前列腺癌患者提供了更多的治疗选择。在这篇综述中,我们将探讨这一充满活力的领域及其彻底改变前列腺癌精准医疗的潜力。我们深入探讨了基础原理、临床应用和新兴机遇,强调了放射性配体疗法与其他系统治疗之间的潜在协同作用。此外,我们还探讨了当前面临的挑战,包括优化患者选择、评估治疗反应以及确定治疗仪在前列腺癌治疗大环境中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives

In the last years, theranostics has expanded the therapeutic options available for prostate cancer patients. In this review, we explore this dynamic field and its potential to revolutionize precision medicine for prostate cancer. We delve into the foundational principles, clinical applications, and emerging opportunities, emphasizing the potential synergy between radioligand therapy and other systemic treatments. Additionally, we address the ongoing challenges, including optimizing patient selection, assessing treatment responses, and determining the role of theranostics within the broader landscape of prostate cancer treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer treatment reviews
Cancer treatment reviews 医学-肿瘤学
CiteScore
21.40
自引率
0.80%
发文量
109
审稿时长
13 days
期刊介绍: Cancer Treatment Reviews Journal Overview: International journal focused on developments in cancer treatment research Publishes state-of-the-art, authoritative reviews to keep clinicians and researchers informed Regular Sections in Each Issue: Comments on Controversy Tumor Reviews Anti-tumor Treatments New Drugs Complications of Treatment General and Supportive Care Laboratory/Clinic Interface Submission and Editorial System: Online submission and editorial system for Cancer Treatment Reviews
期刊最新文献
Progress toward personalized management of stage II/III triple negative breast cancer Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors Circulating tumor DNA for predicting recurrence and mortality in patients with resected Melanoma: A systematic review and meta-analysis KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians Comprehensive genomic profiling in solid tumours: Navigating promise, challenges, and pathways to clinical integration
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1